Interventions to Reduce Maternal and Newborn Morbidity and Mortality

A Metin Gülmezoglu, Theresa A Lawrie, Natasha Hezelgrave, Olufemi T Oladapo, João Paulo Souza, Marijke Gielen, Joy E Lawn, Rajiv Bahl, Fernando Althabe, Daniela Colaci, G Justus Hofmeyr, Robert E Black, Ramanan Laxminarayan, Marleen Temmerman, Neff Walker, A Metin Gülmezoglu, Theresa A Lawrie, Natasha Hezelgrave, Olufemi T Oladapo, João Paulo Souza, Marijke Gielen, Joy E Lawn, Rajiv Bahl, Fernando Althabe, Daniela Colaci, G Justus Hofmeyr, Robert E Black, Ramanan Laxminarayan, Marleen Temmerman, Neff Walker

Excerpt

In 2015, an estimated 303,000 women died as a result of pregnancy and childbirth-related complications (WHO 2015a). Most of these deaths occurred in low- and middle-income countries (LMICs). Sub-Saharan Africa had the highest maternal mortality ratio (MMR) in 2015, an estimated 546 maternal deaths per 100,000 live births; the MMR for high-income countries (HICs) was an estimated 17 maternal deaths per 100,000 live births (map 7.1) (WHO 2015a). Although significant progress has been made since 1990 in achieving the Millennium Development Goals (MDGs), with a reduction in the global MMR from 385 to 216 maternal deaths per 100,000 live births, this reduction falls short of the 2015 MDG 5 target of a 75 percent reduction.

Similarly, mortality for children under age five years (MDG 4) declined by 49 percent, from 12.4 million in 1990 to 5.9 million in 2015, but still substantially short of the 2015 target of a reduction by two-thirds, and the decline is much slower for neonatal deaths (Liu and others 2016). Within countries, when the population is disaggregated by income, education, or place of residence, wide disparities in child mortality can be shown, even in those areas where the overall mortality seems low. Respiratory infections, diarrhea, and malaria remain important causes of under-five mortality after the first month of life (Liu and others 2016). Neonates account for 45 percent of all deaths under age five years (Liu and others 2016); this share exceeds 50 percent in several regions (Lawn and others 2014). Of all newborn deaths, preterm birth and intrapartum-related complications account for 59 percent (Liu and others 2016), and preterm birth is now the leading direct cause of all deaths under age five years (Lawn and others 2014).

The tracking of progress does not include stillbirths. In 2009, an estimated 2.6 million stillbirths occurred in the last trimester of pregnancy, with more than 45 percent in the intrapartum period (Lawn and others ; Lawn and others 2016). The majority of these stillbirths (98 percent) occur in LMICs (Lawn and others 2014).

Significant proportions of these maternal, fetal, and newborn deaths are preventable. A crucial focus of recent initiatives, such as Ending Preventable Maternal Mortality, is quality of care (WHO 2015b). This chapter discusses biomedical interventions for major causes of morbidity and mortality in pregnancy and childbirth in the context of people’s right to access good quality, respectful, and timely care—wherever they may live.

© 2016 International Bank for Reconstruction and Development / The World Bank.

References

    1. Ahmed A. 2011. “New Insights into the Etiology of Preeclampsia: Identification of Key Elusive Factors for the Vascular Complications.” Thrombosis Research 127 (Suppl. 3): S72–75. doi:10.1016/S0049-3848(11)70020-2.
    1. Alfirevic Z, Devane D, Gyte G M L. 2013. “Continuous Cardiotocography (CTG) as a Form of Electronic Fetal Monitoring (EFM) for Fetal Assessment during Labour.” Cochrane Database of Systematic Reviews (5): CD006066. doi:10.1002/14651858. CD006066.pub2.
    1. Alfirevic Z, Stampalija T, Gyte G M L. 2013. “Fetal and Umbilical Doppler Ultrasound in High-Risk Pregnancies.” Cochrane Database of Systematic Reviews (11): CD007529. doi:10.1002/14651858.CD007529.pub3.
    1. Alkire B C, Vincent J R, Burns C T, Metzler I S, Farmer P E, and others. 2012. “Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention.” PLoS One 7 (4): e34595.
    1. Althabe F, Belizan J M, McClure E M, Hemingway-Foday J, Berrueta M, and others. 2015. “A Population-Based, Multifaceted Strategy to Implement Antenatal Corticosteroid Treatment versus Standard Care for the Reduction of Neonatal Mortality Due to Preterm Birth in Low-Income and Middle-Income Countries: The ACT Cluster-Randomised Trial.” The Lancet 385 (9968): 629–39.
    1. Altman D, Carroli G, Duley L, Farrell B, Moodley J, and others. 2002. “Magpie Trial Collaboration Group. Do Women with Pre-Eclampsia, and Their Babies, Benefit from Magnesium Sulphate? The Magpie Trial: A Randomised Placebo-Controlled Trial.” The Lancet 359 (9321): 1877–90.
    1. Alwan N, Tuffnell D J, West J. 2009. “Treatments for Gestational Diabetes.” Cochrane Database of Systematic Reviews (3): CD003395. doi:10.1002/14651858.CD003395.pub2.
    1. Athukorala C, Middleton P, Crowther C A. 2006. “Intrapartum Interventions for Preventing Shoulder Dystocia.” Cochrane Database of Systematic Reviews (4): CD005543. doi:10.1002/14651858.CD005543.pub2.
    1. Atkins D, Best D, Briss P A, Eccles M, Falck-Ytter Y, and others. 2004. “Grading Quality of Evidence and Strength of Recommendations.” British Medical Journal 328 (7454): 1490.
    1. Betran A P, Torloni M R, Zhang J, Ye J, Mikolajczyk R, and others. 2015. “What Is the Optimal Rate of Caesarean Section at Population Level? A Systematic Review of Ecologic Studies.” Reproductive Health 12: 57. doi:10.1186 /s12978-015-0043-6.
    1. Bhutta Z A, Das J K, Bahl R, Lawn J E, Salam R A, and others. 2014. “Can Available Interventions End Preventable Deaths in Mothers, Newborn Babies, and Stillbirths, and at What Cost?” The Lancet 384 (9940): 347–70.
    1. Blencowe H, Cousens S, Modell B, Lawn J. 2010. “Folic Acid to Reduce Neonatal Mortality from Neural Tube Disorders.” International Journal of Epidemiology 39 (Suppl. 1): i110–21. doi:10.1093/ije/dyq028.
    1. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. 2010. “Tetanus Toxoid Immunization to Reduce Mortality from Neonatal Tetanus.” International Journal of Epidemiology 39 (Suppl. 1): i102–9. doi:10.1093/ije/dyq027.
    1. Blencowe H, Cousens S, Kamb M, Berman S, Lawn J E. 2011. “Lives Saved Tool Supplement Detection and Treatment of Syphilis in Pregnancy to Reduce Syphilis Related Stillbirths and Neonatal Mortality.” BMC Public Health 11 (Suppl 3): S9. doi:10.1186/1471-2458-11-S3-S9.
    1. Brown H C, Paranjothy S, Dowswell T, Thomas J. 2013. “Package of Care for Active Management in Labour for Reducing Caesarean Section Rates in Low-Risk Women.” Cochrane Database of Systematic Reviews (9): CD004907. doi:10.1002/14651858.CD004907.pub3.29.
    1. Bruce N G, Dherani M K, Das J K, Balakrishnan K, Adair-Rohani H, and others. 2013. “Control of Household Air Pollution for Child Survival: Estimates for Intervention Impacts.” BMC Public Health 13 (Suppl. 3): S8. doi:10.1186/1471-2458-13-S3-S8.
    1. Buppasiri P, Lumbiganon P, Thinkhamrop J, Thinkhamrop B. 2010. “Antibiotic Prophylaxis for Third-and Fourth-Degree Perineal Tear during Vaginal Birth.” Cochrane Database of Systematic Reviews (11): Cd005125. doi:10.1002/14651858.CD005125.pub3
    1. Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M. 2011. “Calcium Supplementation (Other than for Preventing or Treating Hypertension) for Improving Pregnancy and Infant Outcomes.” Cochrane Database of Systematic Reviews (10): CD007079. doi:10.1002/14651858.CD007079.pub2.
    1. Carlo W A, Goudar S S, Jehan I, Chomba E, Tshefu A, and others. 2010. “Newborn-Care Training and Perinatal Mortality in Developing Countries.” New England Journal of Medicine 362 (7): 614–23. doi:10.1056/NEJMsa0806033.
    1. Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, Lumbiganon P, DeSimone J A, and others. 2012. “Pneumococcal Vaccination during Pregnancy for Preventing Infant Infection.” Cochrane Database of Systematic Reviews (7): CD004903. doi:10.1002/14651858. CD004903.pub3.
    1. Chappell L C, Duckworth S, Seed P T, Griffin M, Myers J, and others. 2013. “Diagnostic Accuracy of Placental Growth Factor in Women with Suspected Preeclampsia: A Prospective Multicenter Study.” Circulation 128: 2121–31. doi:10.1161/CIRCULATIONAHA.113.003215.
    1. Churchill D, Duley L, Thornton J G, Jones L. 2013. “Interventionist versus Expectant Care for Severe Pre-Eclampsia between 24 and 34 Weeks’ Gestation.” Cochrane Database of Systematic Reviews (7): CD003106. doi:10.1002/14651858.CD003106.pub2.
    1. Conde-Agudelo A, Belizán J M, Diaz-Rossello J. 2014. “Kangaroo Mother Care to Reduce Morbidity and Mortality in Low Birthweight Infants.” Cochrane Database of Systematic Reviews (4): CD002771. doi:10.1002/14651858.CD002771.pub3.
    1. Cournil A, Van de Perre P, Cames C, de Vincenzi I, Read J S, and others. 2015. “Early Infant Feeding Patterns and HIV-Free Survival: Findings from the Kesho-Bora Trial (Burkina Faso, Kenya, South Africa).” Pediatric Infectious Disease Journal 34 (2): 168–74.
    1. Deneux-Tharaux C, Sentilhes L, Maillard F, Closset E, Vardon D, and others. 2013. “Effect of Routine Controlled Cord Traction as Part of the Active Management of the Third Stage of Labour on Postpartum Haemorrhage: Multicentre Randomised Controlled Trial (TRACOR).” British Medical Journal 346: f1541. doi:10.1136/bmj.f1541.
    1. De-Regil L M, Fernández-Gaxiola A C, Dowswell T, Peña-Rosas J P. 2010. “Effects and Safety of Periconceptional Folate Supplementation for Preventing Birth Defects.” Cochrane Database of Systematic Reviews (10): CD007950. doi: 10.1002/14651858.CD007950.pub2.
    1. Diemert A, Ortmeyer G, Hollwitz B, Lotz M, Somville T, and others. 2012. “The Combination of Intrauterine Balloon Tamponade and the B-Lynch Procedure for the Treatment of Severe Postpartum Hemorrhage.” American Journal of Obstetrics and Gynecology 206 (1): 65.e1–4. doi:10.1016/j.ajog.2011.07.041.
    1. Dijk P H, Hulzebos C V. 2012. “An Evidence-Based View on Hyperbilirubinaemia.” Acta Paediatrica Supplement 101 (464): 3–10. doi:10.1111/j.1651-2227.2011.02544.x.
    1. Di Renzo G C, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, and others. 2014. “Intrapartum GBS Screening and Antibiotic Prophylaxis: A European Consensus Conference.” Journal of Maternal, Fetal and Neonatal Medicine 28 (7): 766–82.
    1. Dodd J M, McLeod A, Windrim R C, Kingdom J. 2013. “Antithrombotic Therapy for Improving Maternal or Infant Health Outcomes in Women Considered at Risk of Placental Dysfunction.” Cochrane Database of Systematic Reviews (6): CD006780. doi: 10.1002/14651858.CD006780.pub3.
    1. Dowswell T, Carroli G, Duley L, Gates S, Gülmezoglu A M, and others. 2010. “Alternative versus Standard Packages of Antenatal Care for Low-Risk Pregnancy.” Cochrane Database of Systematic Reviews 10: CD000934. doi:10.1002/14651858.CD000934.pub2.
    1. Doyle L W, Crowther C A, Middleton P, Marret S, Rouse D. 2009. “Magnesium Sulphate for Women at Risk of Preterm Birth for Neuroprotection of the Fetus.” Cochrane Database of Systematic Reviews (1): CD004661. doi:10.1002/14651858. CD004661.pub3.
    1. Duley L. 2009. “The Global Impact of Pre-Eclampsia and Eclampsia.” Seminars in Perinatology 33: 130–37. doi:10.1053/j.semperi.2009.02.010.
    1. Duley L, Gülmezoglu A M, Henderson-Smart D J, Chou D. 2010. “Magnesium Sulphate and other Anticonvulsants for Women with Pre-Eclampsia.” Cochrane Database of Systematic Reviews 11: CD000025. doi:10.1002/14651858.CD000025.pub2.
    1. Duley L, Henderson-Smart D J, Chou D. 2010. “Magnesium Sulphate versus Phenytoin for Eclampsia.” Cochrane Database of Systematic Reviews 10: CD000128. doi:10.1002/14651858.CD000128.pub2.
    1. Duley L, Henderson-Smart D J, Meher S, King J F. 2007. “Antiplatelet Agents for Preventing Preeclampsia and Its Complications.” Cochrane Database of Systematic Reviews (2): CD004659. doi:10.1002/14651858.CD004659.pub2.
    1. Duley L, Matar H E, Almerie M Q, Hall D R. 2010. “Alternative Magnesium Sulphate Regimens for Women with Pre-Eclampsia and Eclampsia.” Cochrane Database of Systematic Reviews (8): CD007388. doi:10.1002/14651858. CD007388.pub2.
    1. Erim D O, Resch S C, Goldie S J. 2012. “Assessing Health and Economic Outcomes of Interventions to Reduce Pregnancy-Related Mortality in Nigeria.” BMC Public Health 12: 786. doi:10.1186/1471-2458-12-786.
    1. Evans D J, Levene M, Tsakmakis M. 2007. “Anticonvulsants for Preventing Mortality and Morbidity in Full Term Newborns with Perinatal Asphyxia.” Cochrane Database of Systematic Reviews (3): CD001240. doi:10.1002/14651858.CD001240.pub2.
    1. Flenady V, Hawley G, Stock O M, Kenyon S, Badawi N. 2013. “Prophylactic Antibiotics for Inhibiting Preterm Labour with Intact Membranes.” Cochrane Database of Systematic Reviews 12: CD000246. doi:10.1002/14651858. CD000246.pub2.
    1. Fottrell E, Azad K, Kuddus A, Younes L, Shaha S, and others. 2013. “The Effect of Increased Coverage of Participatory Women’s Groups on Neonatal Mortality in Bangladesh: A Cluster Randomized Trial.” JAMA Pediatrics 167 (9): 816–25.
    1. French L, Smaill F M. 2004. “Antibiotic Regimens for Endometritis after Delivery.” Cochrane Database of Systematic Reviews (4): CD001067. doi:10.1002/14651858.CD001067.pub2.
    1. Gamble C L, Ekwaru J P, ter Kuile F O. 2006. “Insecticide-Treated Nets for Preventing Malaria in Pregnancy.” Cochrane Database of Systematic Reviews (2): CD003755. doi:10.1002/14651858.CD003755.pub2.
    1. Ganguli S, Stecker M S, Pyne D, Baum R A, Fan C M. 2011. “Uterine Artery Embolization in the Treatment of Postpartum Uterine Hemorrhage.” Journal of Vascular and Interventional Radiology 22 (2): 169–76. doi:10.1016/j.jvir.2010.09.031.
    1. Georgiou C. 2009. “Balloon Tamponade in the Management of Postpartum Haemorrhage: A Review.” British Journal of Obstetrics and Gynaecology 116 (6): 748–57. doi:10.1111/j.1471-0528.2009.02113.x.
    1. Gibbons L, Belizán J M, Lauer J A, Betrán A P, Merialdi M, and others. 2010. “The Global Numbers and Costs of Additionally Needed and Unnecessary Caesarean Sections Performed per Year: Overuse as a Barrier to Universal Coverage.” World Health Report (2010), Background paper 30. .
    1. Gomez G B, Kamb M L, Newman L M, Mark J, Broutet N, Hawkes S J. 2013. “Untreated Maternal Syphilis and Adverse Outcomes of Pregnancy: A Systematic Review and Meta-Analysis.” Bulletin of the World Health Organization 91 (3): 217–26. doi:10.2471/BLT.12.107623.
    1. Gülmezoglu A M, Crowther C A, Middleton P, Heatley E. 2012. “Induction of Labour for Improving Birth Outcomes for Women at or Beyond Term.” Cochrane Database of Systematic Reviews (6): CD004945. doi:10.1002/14651858.CD004945.pub3.
    1. Gülmezoglu A M, Lumbiganon P, Landoulsi S, Widmer M, Abdel-Aleem H, and others. 2012. “Active Management of the Third Stage of Labour with and without Controlled Cord Traction: A Randomised, Controlled, Non-Inferiority Trial.” The Lancet 379 (9827): 1721–27. doi:10.1016/S0140-6736(12)60206-2.
    1. Haas D M, Morgan S, Contreras K. 2013. “Vaginal Preparation with Antiseptic Solution before Cesarean Section for Preventing Postoperative Infections.” Cochrane Database of Systematic Reviews (1): CD007892. doi:10.1002/14651858.CD007892.pub3.
    1. Haroon S, Das J K, Salam R A, Imdad A, Bhutta Z A. 2013. “Breastfeeding Promotion Interventions and Breastfeeding Practices: A Systematic Review.” BMC Public Health 13 (3): 1–18. doi:10.1186/1471-2458-13-S3-S20.
    1. Harrison M S, Ali A, Pasha O, Saleem S, Althabe F, and others. 2015. “A Prospective Population-Based Study of Maternal, Fetal, and Neonatal Outcomes in the Setting of Prolonged Labor, Obstructed Labor and Failure to Progress in Low- and Middle-income Countries.” Reproductive Health 12 (suppl 2): S9.
    1. Hofmeyr G J, Abdel-Aleem H, Abdel-Aleem M A. 2013. “Uterine Massage for Preventing Postpartum Haemorrhage.” Cochrane Database of Systematic Reviews (7): CD006431. doi:10.1002/14651858.CD006431.pub3.
    1. Hofmeyr G J, Gülmezoglu A M, Novikova N, Lawrie T A. 2013. “Postpartum Misoprostol for Preventing Maternal Mortality and Morbidity.” Cochrane Database of Systematic Reviews (7): CD008982. doi:10.1002/14651858. CD008982.pub2.
    1. Hofmeyr G J, Hodnett E D. 2013. “Antenatal Care Packages with Reduced Visits and Perinatal Mortality: A Secondary Analysis of the WHO Antenatal Care Trial— Commentary: Routine Antenatal Visits for Healthy Pregnant Women Do Make a Difference.” Reproductive Health 10: 20.
    1. Hofmeyr G J, Kulier R, West H M. 2015. “External Cephalic Version for Breech Presentation at Term.” Cochrane Database of Systematic Reviews (4): CD000083.
    1. Hofmeyr G J, Lawrie T A, Atallah Á N, Duley L, Torloni M R. 2014. “Calcium Supplementation during Pregnancy for Preventing Hypertensive Disorders and Related Problems.” Cochrane Database of Systematic Reviews (8): CD001059. doi:10.1002/14651858. CD001059.pub3.
    1. Hofmeyr G J, Shweni P M. 2012. “Symphysiotomy for Feto-Pelvic Disproportion.” Cochrane Database of Systematic Reviews (10): CD005299. doi:10.1002/14651858. CD005299.pub3.
    1. Hopkins L, Smaill F M. 2002. “Antibiotic Regimens for Management of Intraamniotic Infection.” Cochrane Database of Systematic Reviews (3): CD003254. doi:10.1002/14651858.CD003254.
    1. Horton S, Levin C. 2016. “Cost-Effectiveness of Interventions for Reproductive, Maternal, Neonatal, and Child Health.” In Disease Control Priorities (third edition): Volume 2, Reproductive, Maternal, Newborn, and Child Health, edited by Black R, Laxminarayan R, Temmerman M, Walker N. Washington, DC: World Bank.
    1. Imdad A, Bautista R M M, Senen K A A, Uy M E V, Mantaring III J B, and others. 2013. “Umbilical Cord Antiseptics for Preventing Sepsis and Death among Newborns.” Cochrane Database of Systematic Reviews (5): CD008635. doi:10.1002/14651858. CD008635.pub2.
    1. Imdad A, Bhutta Z A. 2012. “Maternal Nutrition and Birth Outcomes: Effect of Balanced Protein-Energy Supplementation.” Paediatric and Perinatal Epidemiology 26 (Suppl. 1): 178–90. doi:10.1111/j.1365-3016.2012.01308.x.
    1. Imdad A, Yakoob M Y, Siddiqui S, Bhutta Z A. 2011. “Screening and Triage of Intrauterine Growth Restriction (IUGR) in General Population and High Risk Pregnancies: A Systematic Review with a Focus on Reduction of IUGR Related Stillbirths.” BMC Public Health 11 (Suppl. 3): S1. doi:10.1186/1471-2458-11-S3-S1.
    1. Jacobs S E, Berg M, Hunt R, Tarnow-Mordi W O, Inder T E, and others. 2013. “Cooling for Newborns with Hypoxic Ischaemic Encephalopathy.” Cochrane Database of Systematic Reviews (1): CD003311. doi:10.1002/14651858. CD003311.pub3.
    1. Kenyon S, Boulvain M, Neilson J P. 2013. “Antibiotics for Preterm Rupture of Membranes.” Cochrane Database of Systematic Reviews (12): CD001058. doi:10.1002/14651858.CD001058.pub3.
    1. Khan K S, Wojdyla D, Say L, Gülmezoglu A M, Van Look P F. 2006. “WHO Analysis of Causes of Maternal Death: A Systematic Review.” The Lancet 367 (9516): 1066–74.
    1. Kirby J M, Kachura J R, Rajan D K, Sniderman K W, Simons M E, and others. 2009. “Arterial Embolization for Primary Postpartum Hemorrhage.” Journal of Vascular and Interventional Radiology 20 (8): 1036–45. doi:10.1016/j.jvir.2009.04.070.
    1. Koopmans C M, Bijlenga D, Groen H, Vijgen S M, Aarnoudse J G, and others. 2009. “Induction of Labour versus Expectant Monitoring for Gestational Hypertension or Mild Pre-Eclampsia after 36 Weeks’ Gestation (HYPITAT): A Multicentre, Open-Label Randomised Controlled Trial.” The Lancet 374 (9694): 979–88. doi:10.1016/S0140-6736(09)60736-4.
    1. Kramer M S, Kakuma R. 2012. “Optimal Duration of Exclusive Breastfeeding.” Cochrane Database of Systematic Reviews (8): CD003517. doi:10.1002/14651858. CD003517.pub2.
    1. Lassi Z S, Bhutta Z A. 2013. “Risk Factors and Interventions Related to Maternal and Pre-Pregnancy Obesity, Pre-Diabetes and Diabetes for Maternal, Fetal and Neonatal Outcomes: A Systematic Review.” Expert Review of Obstetrics and Gynecology 8 (6): 639–60.
    1. Lavender T, Hart A, Smyth R M D. 2013. “Effect of Partogram Use on Outcomes for Women in Spontaneous Labour at Term.” Cochrane Database of Systematic Reviews (7): CD005461. doi:10.1002/14651858.CD005461.pub4.
    1. Lawn J E, Blencowe H, Oza S, You D, Lee A C, and others. 2014. “Every Newborn: Progress, Priorities, and Potential beyond Survival.” The Lancet 384 (9938): 189–205.
    1. Lawn J E, Blencowe H, Pattinson R, Cousens S, Kumar R, and others. 2011. “Stillbirths: Where? When? Why? How to Make the Data Count?” The Lancet 377 (9775): 1448–63.
    1. Lawn J, Blencowe H, Waiswa P, Amouzou A, Mathers C, and others. 2016. “Stillbirths: Rate, Risk Factors, and Acceleration towards 2030.” The Lancet 387: 587–603.
    1. Lee J S, Shepherd S M. 2010. “Endovascular Treatment of Postpartum Hemorrhage.” Clinical Obstetrics and Gynecology 53 (1): 209–18. doi:10.1097/GRF.0b013e3181ce09f5.
    1. LeFevre A E, Shillcutt S D, Waters H R, Haider S, El Arifeen S, and others. 2013. “Economic Evaluation of Neonatal Care Packages in a Cluster-Randomized Controlled Trial in Sylhet, Bangladesh.” Bulletin of the World Health Organization 91 (10): 736–45.
    1. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam Q M. 2004. “Antibiotic Prophylaxis for Operative Vaginal Delivery.” Cochrane Database of Systematic Reviews (3): CD004455. doi:10.1002/14651858.CD004455.pub2.
    1. Liu L, Hill K, Oza S, Hogan D, Chu Y, and others. 2016. “Levels and Causes of Mortality under Age Five Years.” In Disease Control Priorities (third edition): Volume 2, Reproductive, Maternal, Newborn, and Child Health, edited by Black R, Laxminarayan R, Temmerman M, Walker N. Washington, DC: World Bank.
    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, and others. 2012. “Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010.” The Lancet 380 (9859): 2095–128.
    1. Lumbiganon P, Thinkhamrop J, Thinkhamrop B, Tolosa J E. 2004. “Vaginal Chlorhexidine during Labour for Preventing Maternal and Neonatal Infections (Excluding Group B Streptococcal and HIV).” Cochrane Database of Systematic Reviews (4): CD004070. doi:10.1002/14651858. CD004070.pub2.
    1. Maisels M J, Watchko J F, Bhutani V K, Stevenson D K. 2012. “An Approach to the Management of Hyperbilirubinaemia in the Preterm Infant Less than 35 Weeks Gestation.” Journal of Perinatology 32 (9): 660–64. doi:10.1038/jp.2012.71.
    1. Majumdar A, Saleh S, Davis M, Hassan I, Thompson P J. 2010. “Use of Balloon Catheter Tamponade for Massive Postpartum Haemorrhage.” Journal of Obstetrics and Gynaecology 30 (6): 586–93. doi:10.3109/01443615.2010.494202.
    1. Mangesi L, Hofmeyr G J, Smith V. 2007. “Fetal Movement Counting for Assessment of Fetal Wellbeing.” Cochrane Database of Systematic Reviews (1): CD004909. doi:10.1002/14651858.CD004909.pub2.
    1. Mangham-Jefferies L, Pitt C, Cousens S, Mills A, Schellenberg J. 2014. “Cost-Effectiveness of Strategies to Improve the Utilization and Provision of Maternal and Newborn Health Care in Low-Income and Lower-Middle-Income Countries: A Systematic Review.” BMC Pregnancy Childbirth 14: 243. doi:10.1186/1471-2393-14-243.
    1. McDonald S J, Middleton P, Dowswell T, Morris P S. 2013. “Effect of Timing of Umbilical Cord Clamping of Term Infants on Maternal and Neonatal Outcomes.” Cochrane Database of Systematic Reviews (7): CD004074. doi:10.1002/14651858.CD004074.pub3.
    1. Mistry H D, Wilson V, Ramsay M M, Symonds M E, Broughton Pipkin F. 2008. “Reduced Selenium Concentrations and Glutathione Peroxidase Activity in Pre-Eclamptic Pregnancies.” Hypertension 52 (5): 881–88. doi:10.1161/HYPERTENSIONAHA.108.116103.
    1. Mori R, Ota E, Middleton P, Tobe-Gai R, Mahomed K, and others. 2012. “Zinc Supplementation for Improving Pregnancy and Infant Outcome.” Cochrane Database of Systematic Reviews (7): CD000230. doi:10.1002/14651858.CD000230.pub4.
    1. Mousa H A, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. 2014. “Treatment for Primary Postpartum Haemorrhage.” Cochrane Database of Systematic Reviews (2): CD003249. doi:10.1002/14651858.CD003249.pub3.
    1. Ngoc N T, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, and others. 2006. “Causes of Stillbirths and Early Neonatal Deaths: Data from 7993 Pregnancies in Six Developing Countries.” Bulletin of the World Health Organization 84: 699–705.
    1. Nguyen T M N, Crowther C A, Wilkinson D, Bain E. 2013. “Magnesium Sulphate for Women at Term for Neuroprotection of the Fetus.” Cochrane Database of Systematic Reviews (2): CD009395. doi:10.1002/14651858. CD009395.pub2.
    1. Ohlsson A, Shah V S. 2014. “Intrapartum Antibiotics for Known Maternal Group B Streptococcal Colonization.” Cochrane Database of Systematic Reviews (6): CD007467. doi:10.1002/14651858.CD007467.pub4.
    1. O’Mahony F, Hofmeyr G J, Menon V. 2010. “Choice of Instruments for Assisted Vaginal Delivery.” Cochrane Database of Systematic Reviews (11): CD005455. doi:10.1002/14651858.CD005455.pub2.
    1. Opiyo N, English M. 2010. “In-Service Training for Health Professionals to Improve Care of the Seriously Ill Newborn or Child in Low and Middle-Income Countries (Review).” Cochrane Database of Systematic Reviews (4): CD007071. doi:10.1002/14651858.CD007071.pub2.
    1. Ota E, Tobe-Gai R, Mori R, Farrar D. 2012. “Antenatal Dietary Advice and Supplementation to Increase Energy and Protein Intake.” Cochrane Database of Systematic Reviews (9): CD000032. doi:10.1002/14651858.CD000032.pub2.
    1. Owusu J T, Anderson F J, Coleman J, Oppong S, Seffah J D, and others. 2013. “Association of Maternal Sleep Practices with Pre-Eclampsia, Low Birth Weight, and Stillbirth among Ghanaian Women.” International Journal of Gynecology and Obstetrics 121 (3): 261–65. doi:10.1016/j.ijgo.2013.01.013.
    1. Pasha O, McClure E M, Wright L L, Saleem S, Goudar S S, and others. 2013. “A Combined Community- and Facility-Based Approach to Improve Pregnancy Outcomes in Low-Resource Settings: A Global Network Cluster Randomized Trial.” BMC Medicine 11: 215.
    1. Perel P, Roberts I, Ker K. 2013. “Colloids versus Crystalloids for Fluid Resuscitation in Critically Ill Patients.” Cochrane Database of Systematic Reviews (2): CD000567. doi:10.1002/14651858.CD000567.pub6.
    1. Porreco R P, Stettler R W. 2010. “Surgical Remedies for Postpartum Hemorrhage.” Clinical Obstetrics and Gynecology 53 (1): 182–95. doi:10.1097/GRF.0b013e3181cc4139.
    1. Price N, Lynch C B. 2005. “Technical Description of the B-Lynch Brace Suture for Treatment of Massive Postpartum Hemorrhage and Review of Published Cases.” International Journal of Fertility and Women’s Medicine 50 (4): 148–63.
    1. Radeva-Petrova D, Kayentao K, ter Kuile F O, Sinclair D, Garner P. 2014. “Drugs for Preventing Malaria in Pregnant Women in Endemic Areas: Any Drug Regimen versus Placebo or No Treatment.” Cochrane Database of Systematic Reviews (10): CD000169.
    1. Roberts D, Dalziel S R. 2006. “Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth.” Cochrane Database of Systematic Reviews (3): CD004454. doi:10.1002/14651858.CD004454.pub2.
    1. Rojas-Reyes M X, Morley C J, Soll R. 2012. “Prophylactic versus Selective Use of Surfactant in Preventing Morbidity and Mortality in Preterm Infants.” Cochrane Database of Systematic Reviews (3): CD000510. doi:10.1002/14651858.CD000510.pub2.
    1. Sabin L L, Knapp A B, MacLeod W B, Phiri-Mazala G, Kasimba J, and others. 2012. “Costs and Cost-Effectiveness of Training Traditional Birth Attendants to Reduce Neonatal Mortality in the Lufwanyama Neonatal Survival Study (LUNESP).” PLoS One 7 (4): e35560.
    1. Salam R A, Das J K, Bhutta Z A. 2012. “Impact of Haemophilus Influenza Type B (Hib) and Viral Influenza Vaccinations in Pregnancy for Improving Maternal, Neonatal and Infant Health Outcomes.” Cochrane Database of Systematic Reviews (7): CD009982. doi:10.1002/14651858.CD009982.
    1. Saleem S, McClure E M, Goudar S S, Patel A, Esamai F, and others. 2014. “A Prospective Study of Maternal, Fetal and Neonatal Deaths in Low- and Middle-Income Countries.” Bulletin of the World Health Organization 92 (8): 605–12.
    1. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A B, and others. 2014. “Global Causes of Maternal Death: A WHO Systematic Analysis.” The Lancet 6: e323–33. doi:10.1016/S2214-109X(14)70227-X. Epub May 5.
    1. Seger N, Soll R. 2009. “Animal Derived Surfactant Extract for Treatment of Respiratory Distress Syndrome.” Cochrane Database of Systematic Reviews (2): CD007836. doi:10.1002/14651858.CD007836.
    1. Seward N, Osrin D, Li L, Costello A, Pulkki-Brännström A M, and others. 2012. “Association between Clean Delivery Kit Use, Clean Delivery Practices, and Neonatal Survival: Pooled Analysis of Data from Three Sites in South Asia.” PLoS Medicine 9 (2): e1001180. doi:10.1371/journal.pmed.1001180.
    1. Sheikh L, Najmi N, Khalid U, Saleem T. 2011. “Evaluation of Compliance and Outcomes of a Management Protocol for Massive Postpartum Hemorrhage at a Tertiary Care Hospital in Pakistan.” BMC Pregnancy and Childbirth 11: 28. doi:10.1186/1471-2393-11-28.
    1. Siegfried N, van der Merwe L, Brocklehurst P, Sint T T. 2011. “Antiretrovirals for Reducing the Risk of Mother-to-Child Transmission of HIV Infection.” Cochrane Database of Systematic Reviews (7): CD003510.
    1. Sinha A, Sazawal S, Pradhan A, Ramji S, Opiyo N. 2015. “Chlorhexidine Skin or Cord Care for Prevention of Mortality and Infections in Neonates.” Cochrane Database of Systematic Reviews (3): CD007835.
    1. Smaill F M, Grivell R M. 2014. “Antibiotic Prophylaxis versus no Prophylaxis for Preventing Infection after Cesarean Section.” Cochrane Database of Systematic Reviews (10): CD007482. doi:10.1002/14651858.CD007482.pub3.
    1. Soll R, Özek E. 2010. “Prophylactic Protein Free Synthetic Surfactant for Preventing Morbidity and Mortality in Preterm Infants.” Cochrane Database of Systematic Reviews (1): CD001079. doi:10.1002/14651858.CD001079.pub2.
    1. Souza J P, Gülmezoglu A M, Vogel J, Carroli G, Lumbiganon P, and others. 2013. “Moving beyond Essential Interventions for Reduction of Maternal Mortality (the WHO Multi-Country Survey on Maternal and Newborn Health): A Cross-Sectional Study.” The Lancet 381 (9879): 1747–55. doi:10.1016/S0140-6736(13)60686-8.
    1. Steegers E A, von Dadelszen P, Duvekot J J, Pijnenborg R. 2010. “Preeclampsia.” The Lancet 376 (9741): 631–44. doi:10.1016/S0140-6736(10)60279-6.
    1. Stenberg K, Axelson H, Sheehan P, Anderson I, Gülmezoglu A M, and others. 2013. “Advancing Social and Economic Development by Investing in Women’s and Children’s Health: A New Global Investment Framework.” The Lancet 383 (9925): 1333–54. doi:10.1016/S0140-6736(13)62231-X.
    1. Syed M, Javed H, Yakoob M Y, Bhutta Z A. 2011. “Effect of Screening and Management of Diabetes during Pregnancy on Stillbirths.” BMC Public Health 11 (Suppl. 3): S2. doi:10.1186/1471-2458-11-S3-S2.
    1. Thapa K, Malla B, Pandey S, Amatya S. 2010. “Intrauterine Condom Tamponade in Management of Postpartum Haemorrhage.” Journal of Nepal Health Research Council 8 (1): 19–22.
    1. Touboul C, Badiou W, Saada J, Pelage J P, Payen D, and others. 2008. “Efficacy of Selective Arterial Embolisation for the Treatment of Life-Threatening Post-Partum Haemorrhage in a Large Population.” PLoS One 3 (11): e3819. doi:10.1371/journal.pone.0003819.
    1. Tunçalp Ö, Hofmeyr G J, Gülmezoglu A M. 2012. “Prostaglandins for Preventing Postpartum Haemorrhage.” Cochrane Database of Systematic Reviews (8): CD000494. doi:10.1002/14651858.CD000494.pub4.
    1. Ungerer R L S, Lincetto O, McGuire W, Saloojee H H, Gülmezoglu A M. 2004. “Prophylactic versus Selective Antibiotics for Term Newborn Infants of Mothers with Risk Factors for Neonatal Infection.” Cochrane Database of Systematic Reviews (4): CD003957. doi:10.1002/14651858.CD003957.pub2.
    1. UNICEF and WHO . 2014. “Countdown to 2015. Maternal, Newborn and Child Survival.” .
    1. van Lonkhuijzen L, Stekelenburg J, van Roosmalen J. 2012. “Maternity Waiting Facilities for Improving Maternal and Neonatal Outcome in Low-Resource Countries.” Cochrane Database of Systematic Reviews (10): CD006759. doi:10.1002/14651858.CD006759.pub3.
    1. Vogel J P, Ndema H A, Souza J P, Gülmezoglu M A, Dowswell T, and others. 2013. “Antenatal Care Packages with Reduced Visits and Perinatal Mortality: A Secondary Analysis of the WHO Antenatal Care Trial.” Reproductive Health 10 (1): 19.
    1. Walker N, Tam Y, Friberg I K. 2013. “Overview of the Lives Saved Tool (LiST).” BMC Public Health 13 (Suppl 3): S1. doi:10.1186/1471-2458-13-S3-S1.
    1. Wang M Q, Liu F Y, Duan F, Wang Z J, Song P, and others. 2009. “Ovarian Artery Embolization Supplementing Hypogastric-Uterine Artery Embolization for Control of Severe Postpartum Hemorrhage: Report of Eight Cases.” Journal of Vascular and Interventional Radiology 20 (7): 971–76.
    1. Westhoff G, Cotter A M, Tolosa J E. 2013. “Prophylactic Oxytocin for the Third Stage of Labour to Prevent Postpartum Haemorrhage.” Cochrane Database of Systematic Reviews (10): CD001808.
    1. WHO . 2010. a. “Integrated Management of Pregnancy and Childbirth (IMPAC).” WHO, Geneva. .
    1. WHO . 2010. b. “PMTCT Strategic Vision 2010–2015.” WHO, Geneva. .
    1. WHO . 2011. a. “Essential Interventions, Commodities and Guidelines for Reproductive Maternal, Newborn, and Child Health.” WHO, Geneva. .
    1. WHO . 2011. b. Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva: WHO.
    1. WHO . 2012. “WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage.” WHO, Geneva. .
    1. WHO . 2013. Guideline: Calcium Supplementation in Pregnant Women. Geneva: WHO.
    1. WHO . 2014. a. “Effect of Partogram Use on Outcomes for Women in Spontaneous Labour at Term.” The WHO Reproductive Health Library. .
    1. WHO . 2014. b. “WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP).” WHO, Geneva.
    1. WHO . 2014. c. WHO Recommendations on Postnatal Care of the Mother and Newborn. Geneva: WHO.
    1. WHO . 2015. a. Trends in Maternal Mortality: 1990 to 2015: Estimates by WHO, UNICEF, UNFPA, World Bank, and the United Nations Population Division. Geneva: WHO.
    1. WHO . 2015. b. “Strategies toward Ending Preventable Maternal Mortality (EPMM).” Geneva, WHO.
    1. WHO Odon Device Research Group . 2013. “Feasibility and Safety Study of a New Device (Odon device) for Assisted Vaginal Deliveries: Study Protocol.” Reproductive Health 10: 33. doi:10.1186/1742-4755-10-33.
    1. Wojcieszek A M, Stock O M, Flenady V. 2014. “Antibiotics for Prelabour Rupture of Membranes at or Near Term.” Cochrane Database of Systematic Reviews (10): CD001807.
    1. Yakoob M Y, Ali M A, Ali M U, Imdad A, Lawn J E, and others. 2011. “The Effect of Providing Skilled Birth Attendance and Emergency Obstetric Care in Preventing Stillbirths.” BMC Public Health 11 (Suppl. 3): S7. doi:10.1186/1471-2458-11-S3-S7.
    1. Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, and others. 2012. “Application of Uterine Compression Suture in Association with Intrauterine Balloon Tamponade (‘Uterine Sandwich’) for Postpartum Hemorrhage.” Acta Obstetricia et Gynecologica Scandinavica 91 (1): 147–51. doi:10.1111/j.1600-0412.2011.01153.x.
    1. Zaidi A K, Ganatra H A, Syed S, Cousens S, Lee A C, and others. 2011. “Effect of Case Management on Neonatal Mortality Due to Sepsis and Pneumonia.” BMC Public Health 11 (Suppl. 3): S13. doi:10.1186/1471-2458-11-S3-S13.
    1. Zwart J J, Dijk P D, van Roosmalen J. 2010. “Peripartum Hysterectomy and Arterial Embolization for Major Obstetric Hemorrhage: A 2-Year Nationwide Cohort Study in the Netherlands.” American Journal of Obstetrics and Gynecology 202 (2): 150. e1–7. doi:10.1016/j.ajog.2009.09.003.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel